CDMO - April 21, 2026
Nanologica receives SEK 2 million order from customer in India
Nanologica has received an order of appx. SEK 2 million for the company’s silica-based purification media NLAB Saga.
New Market - April 7, 2026
Immedica announces first marketing authorization approval in the MENA region
Immedica has announced that the Kuwait Ministry of Health (MOH) has granted Marketing Authorization (MA) approval for Ztalmy (ganaxolone) for the treatment of seizures associated with CDKL5 deficiency disorder (CDD) in Kuwait.
Business article - March 30, 2026
Diamyd reports negative interim Phase 3 results
Diamyd Medical have announced the completion of a pre-specified interim efficacy analysis on C-peptide in the ongoing Phase 3 DIAGNODE-3 trial evaluating retogatein (rhGAD65) in individuals with recent-onset Stage 3 type 1 diabetes carrying the HLA DR3-DQ2 haplotype. The interim analysis that included 174 out of 321 study participants did not demonstrate statistical significance on […]
Agreement - March 23, 2026
Mendus signs agreement with Olivia Newton-John Cancer Research Institute
Mendus has entered into an agreement with the Olivia Newton-John Cancer Research Institute (ONJCRI), an Australian cancer research institute, to support the DIVA trial with the company’s lead product vididencel in acute myeloid leukemia (AML).
Pharma Business - March 4, 2026
Thermo Fisher Scientific opens distribution and labeling center in Uppsala
The company is opening of a new 8,000-square-meter center supporting its immunodiagnostics business in Uppsala.
Financing - March 3, 2026
SynAct Pharma has carried out a directed issue of new shares
Through the directed issue, the company will receive approximately SEK 51.9 million.
